Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
By combining detailed mechanistic insight, safety profiling, disease-stage targeting, and future directions for clinical translation, this review adds meaningful depth to the existing body of literature and serves as a comprehensive guide for researchers developing nanoparticle-based therapies for AD and related neurodegenerative conditions [210,211,212]
Stolk, W.A
No specific DSIP receptor has ever been identified, the original sleep-induction findings have proved difficult to replicate consistently, and its status as a genuine endogenous sleep factor remains contested nearly fifty years after its description
Compared with the TG group, the ALC + TG group exhibited significantly decreased protein and mRNA SREBP2 and HMGCR levels (Figures 6AC)
US$ 20.70
US$ 20.14
US$ 28.85
